In addition, in vitro treatment with recombinant TSP-1, serum from BCIM-SSc patients or the supernatant of previously treated cells increased the proliferation of isolated human muscle-derived fibroblasts and TGF-β levels (Suárez-Calvet et al., 2020). Here, THBS1 is linked to systemic sclerosis.